Wednesday - February 11, 2026
Mass General Brigham-Developed Cholera Vaccine Completes Phase 1 Trial
January 07, 2026
BOSTON, Massachusetts, Jan. 7 [Category: BizHospital] -- Mass General Brigham issued the following news release:

* * *

Mass General Brigham-Developed Cholera Vaccine Completes Phase 1 Trial

*

A team of scientists and physicians at Mass General Brigham has developed a single-dose oral cholera vaccine and tested it in a phase 1 clinical trial, with results published in The Lancet Infectious Diseases.

"The devastating cholera ou . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products